Journal of complementary & integrative medicine · 2026
Evaluation of hepatoprotective effect of Acacia catechu stem bark extract on high fat and high fructose diet induced metabolic dysfunction-associated steatotic liver disease in experimental animals.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chandrakant Vhanale Dinesh, Bandawane Deepti Dinesh, Hajare Pratiksha Kantilal
Аннотация
OBJECTIVES: This study evaluated the hepatoprotective effect of an ethanolic extract of A. catechu stem bark (ACSB) in metabolic dysfunction-associated steatotic liver disease (MASLD) induced by a high-fat and high-fructose (HFHFr) diet.
METHODS: The HFHFr model was developed over 10 weeks. After six weeks of induction, ACSB was administered orally at 100 and 200 mg/kg for four weeks, while the standard group received pioglitazone (3 mg/kg). Biochemical, lipid, inflammatory, and histopathological parameters were evaluated.
RESULTS: HFHFr administration produced significant alterations in lipid, biochemical, inflammatory, and liver function parameters, along with histopathological changes. ACSB treatment improved these alterations in a dose-dependent manner, with 200 mg/kg showing effects.
CONCLUSIONS: ACSB demonstrated hepatoprotective and antihyperlipidemic effects against HFHFr-induced MASLD, potentially associated with its flavonoid and polyphenolic constituents.
METHODS: The HFHFr model was developed over 10 weeks. After six weeks of induction, ACSB was administered orally at 100 and 200 mg/kg for four weeks, while the standard group received pioglitazone (3 mg/kg). Biochemical, lipid, inflammatory, and histopathological parameters were evaluated.
RESULTS: HFHFr administration produced significant alterations in lipid, biochemical, inflammatory, and liver function parameters, along with histopathological changes. ACSB treatment improved these alterations in a dose-dependent manner, with 200 mg/kg showing effects.
CONCLUSIONS: ACSB demonstrated hepatoprotective and antihyperlipidemic effects against HFHFr-induced MASLD, potentially associated with its flavonoid and polyphenolic constituents.